Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality.

Journal: Molecular cancer
PMID:

Abstract

BACKGROUND: Synthetic lethality describes a genetic interaction between two perturbations, leading to cell death, whereas neither event alone has a significant effect on cell viability. This concept can be exploited to specifically target tumor cells. CRISPR viability screens have been widely employed to identify cancer vulnerabilities. However, an approach to systematically infer genetic interactions from viability screens is missing.

Authors

  • Salvatore Benfatto
    BioMed X Institute (GmbH), Im Neuenheimer Feld 583, 69120, Heidelberg, Germany.
  • Özdemirhan Serçin
    BioMed X Institute (GmbH), Im Neuenheimer Feld 583, 69120, Heidelberg, Germany.
  • Francesca R Dejure
    BioMed X Institute (GmbH), Im Neuenheimer Feld 583, 69120, Heidelberg, Germany.
  • Amir Abdollahi
    Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Frank T Zenke
    Translational Innovation Platform Oncology & Immuno-Oncology, Merck KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany.
  • Balca R Mardin
    BioMed X Institute (GmbH), Im Neuenheimer Feld 583, 69120, Heidelberg, Germany. mardin@bio.mx.